Columbia Scientists Join Consortium to Develop New Antivirals for SARS-CoV-2 and Emerging Viruses miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.
Researchers from Columbia Engineering, Fiocruz's Center for Technological Development in Health and the Oswaldo Cruz Institute in Brazil, Memorial Sloan Kettering Cancer Center, and Rockefeller University recently reported that, by combining inhibitors of polymerases and exonucleases enzymes that allow SARS-CoV-2 to reproduce they were able to reduce SARS-CoV-2 replication 10 times more than when using just the polymerase inhibitors.
Columbia Engineering professors Sam Sia and Jingyue Ju discuss what’s known so far about the omicron variant, how updates to the Covid and flu vaccines differ, and why more Covid diagnostic and genomic testing in the United States is needed.